Difference between revisions of "46BR.1N In Silico Inputs"
(Created page with " Return to overview Return to 46BR.1N Fibroblasts {| class="wikitable" ! style="text-ali...") |
|||
| Line 6: | Line 6: | ||
! style="text-align: center;" | Treatment | ! style="text-align: center;" | Treatment | ||
! style="text-align: center; font-weight:bold;" | A23187 | ! style="text-align: center; font-weight:bold;" | A23187 | ||
| − | ! style="text-align: center; font-weight:bold;" | Indomethacin | + | ! style="text-align: center; font-weight:bold;" | Indomethacin and A23187 |
| − | |||
! style="text-align: center; font-weight:bold;" | ATP | ! style="text-align: center; font-weight:bold;" | ATP | ||
! style="text-align: center; font-weight:bold;" | UVR | ! style="text-align: center; font-weight:bold;" | UVR | ||
|- | |- | ||
| style="text-align: center; font-weight:bold;" | Σ AA released (pg/million cells) | | style="text-align: center; font-weight:bold;" | Σ AA released (pg/million cells) | ||
| − | | style="text-align: center;" | 5.43 | + | | style="text-align: center;" | 5.43 x10^5 |
| − | + | | style="text-align: center;" | 2.11 x10^5 | |
| − | | style="text-align: center;" | 2.11 | + | | style="text-align: center;" | 3.29 x10^4 |
| − | + | | style="text-align: center;" | 4.30 x10^5 | |
| − | | style="text-align: center;" | 3.29 | ||
| − | |||
| − | | style="text-align: center;" | 4.30 | ||
| − | |||
|- | |- | ||
| style="text-align: center; font-weight:bold;" | Σ AA released (mM) | | style="text-align: center; font-weight:bold;" | Σ AA released (mM) | ||
| − | | style="text-align: center;" | 1.54 | + | | style="text-align: center;" | 1.54 x10^-4 |
| − | + | | style="text-align: center;" | 6.00 x10^-5 | |
| − | | style="text-align: center;" | 6.00 | + | | style="text-align: center;" | 9.36 x10^-6 |
| − | + | | style="text-align: center;" | 1.22E x10^-4 | |
| − | | style="text-align: center;" | 9.36 | ||
| − | |||
| − | | style="text-align: center;" | 1.22E | ||
| − | |||
|- | |- | ||
| style="text-align: center; font-weight:bold;" | COX-1 (mM) at 0h | | style="text-align: center; font-weight:bold;" | COX-1 (mM) at 0h | ||
| Line 50: | Line 41: | ||
| style="text-align: center;" | x | | style="text-align: center;" | x | ||
| style="text-align: center;" | x | | style="text-align: center;" | x | ||
| − | | style="text-align: center;" | 2.27 | + | | style="text-align: center;" | 2.27 x10^-2 |
| − | |||
|} | |} | ||
Latest revision as of 08:01, 3 June 2019
| Treatment | A23187 | Indomethacin and A23187 | ATP | UVR |
|---|---|---|---|---|
| Σ AA released (pg/million cells) | 5.43 x10^5 | 2.11 x10^5 | 3.29 x10^4 | 4.30 x10^5 |
| Σ AA released (mM) | 1.54 x10^-4 | 6.00 x10^-5 | 9.36 x10^-6 | 1.22E x10^-4 |
| COX-1 (mM) at 0h | x | 1.00
x10^-28 |
x | x |
| COX-2 (mM) at 0h | x | 1.00
x10^-28 |
x | 1.00
x10^-28 |
| COX-2 (mM) at 6h | x | x | x | 2.27 x10^-2 |
